CoChat

Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression

Open access
Yang, Bangkun, Zhang, Ji-chun, Han, Mei, Yao, Wei, Yang, Chun, Ren, Qian, Ma, Min, Chen, Qian-Xue, Hashimoto, Kenji · 2016 · Psychopharmacology

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

RATIONALE: The N-methyl-D-aspartate (NMDA) receptor antagonists, including R-ketamine and rapastinel (formerly GLYX-13), show rapid antidepressant effects in animal models of depression. OBJECTIVE: We compared the rapid and sustained antidepressant effects of R-ketamine and rapastinel in the social defeat stress model. RESULTS: In the tail suspension and forced swimming tests, R-ketamine (10 mg/kg, intraperitoneal (i.p.)) or rapastinel (10 mg/kg, i.p.) significantly attenuated the increased immobility time in the susceptible mice, compared with the vehicle-treated group. In the sucrose preference test, both compounds significantly enhanced the reduced preference in susceptible mice 2, 4, or 7 days after a single injection. All mice were sacrificed 8 days after a single injection. Western blot analyses showed that R-ketamine, but not rapastinel, significantly attenuated the reduced brain-derived neurotrophic factor (BDNF)-TrkB signaling, postsynaptic density protein 95 (PSD-95), and GluA1 (a subtype of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor) in the prefrontal cortex, dentate gyrus, and CA3 of the hippocampus in the susceptible mice. In contrast, both compounds had no effect against the increased BDNF-TrkB signaling, PSD-95, and GluA1 seen in the nucleus accumbens of susceptible mice. Moreover, sustained antidepressant effect of R-ketamine (3 mg/kg, intravenous (i.v.)), but not rapastinel (3 mg/kg, i.v.), was detected 7 days after a single dose. CONCLUSIONS: These results highlight R-ketamine as a longer lasting antidepressant compared with rapastinel in social defeat stress model. It is likely that synaptogenesis including BDNF-TrkB signaling in the prefrontal cortex (PFC) and hippocampus may be required for the mechanisms promoting this sustained antidepressant effect.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00213-016-4399-2

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The schedule of social defeat stress, drug administration, behavioral tests, and brain sampling. a Repeated social defeat stress was performed for 10 days (day 1–day 10). Social interaction test was performed on day 11, and susceptible mice were used in the subsequent experiments. Vehicle (10 ml/kg, i.p.), R-ketamine (10 mg/kg, i.p.), or rapastinel (10 mg/kg, i.p.) was administered (day 12). Locomotion test (LMT) and tail suspension test (TST) were performed 2 and 4 h after a single injection, respectively (day 12). Forced swimming test (FST) was performed 1 day after injection (day 13). One percent sucrose preference test (SPT) was performed 2 days (day 14), 4 days (day 15), and 7 days (day 19) after injection. Collection of brain regions was performed at day 20. b Repeated social defeat stress was performed for 10 days (day 1–day 10). Social interaction test was performed on day 11, and susceptible mice were used in the subsequent experiments. Vehicle (5 ml/kg, i.v.), R-ketamine (3 mg/kg, i.v.), or rapastinel (3 mg/kg, i.v.) was administered (day 12). LMT and TST were performed 2 and 4 h after a single injection, respectively, (day 12). FST was performed 1 day after injection (day 13). One percent SPT was performed 2 days (day 14), 4 days (day 15), and 7 days (day 19) after a single injection
Fig. 1 The schedule of social defeat stress, drug administration, behavioral tests, and brain sampling. a Repeated social defeat stress was performed for 10 days (day 1–day 10). Social interaction test was performed on day 11, and susceptible mice were used in the subsequent experiments. Vehicle (10 ml/kg, i.p.), R-ketamine (10 mg/kg, i.p.), or rapastinel (10 mg/kg, i.p.) was administered (day 12). Locomotion test (LMT) and tail suspension test (TST) were performed 2 and 4 h after a single injection, respectively (day 12). Forced swimming test (FST) was performed 1 day after injection (day 13). One percent sucrose preference test (SPT) was performed 2 days (day 14), 4 days (day 15), and 7 days (day 19) after injection. Collection of brain regions was performed at day 20. b Repeated social defeat stress was performed for 10 days (day 1–day 10). Social interaction test was performed on day 11, and susceptible mice were used in the subsequent experiments. Vehicle (5 ml/kg, i.v.), R-ketamine (3 mg/kg, i.v.), or rapastinel (3 mg/kg, i.v.) was administered (day 12). LMT and TST were performed 2 and 4 h after a single injection, respectively, (day 12). FST was performed 1 day after injection (day 13). One percent SPT was performed 2 days (day 14), 4 days (day 15), and 7 days (day 19) after a single injectionCC BY · PubMed Central
Fig. 2 Effects of i.p. administration of R-ketamine and rapastinel in social defeat stress model. a LMT (day 12), b TST (day 12), c FST (day 13), d SPT (day 14), e SPT (day 16), and f SPT (day 19). The values represent the mean ± SEM (n = 9 or 10). *P < 0.05, **P < 0.01, ***P < 0.001 compared with the vehicle-treated stress group. # P < 0.05, ## P < 0.01 compared with R-ketamine treated stress group. N.S. not significant, Con control, Veh vehicle, R-Ket R-ketamine, Rap rapastinel, LMT locomotion test, TST tail suspension test, FST forced swimming test, SPT 1 % sucrose preference test
Fig. 2 Effects of i.p. administration of R-ketamine and rapastinel in social defeat stress model. a LMT (day 12), b TST (day 12), c FST (day 13), d SPT (day 14), e SPT (day 16), and f SPT (day 19). The values represent the mean ± SEM (n = 9 or 10). *P < 0.05, **P < 0.01, ***P < 0.001 compared with the vehicle-treated stress group. # P < 0.05, ## P < 0.01 compared with R-ketamine treated stress group. N.S. not significant, Con control, Veh vehicle, R-Ket R-ketamine, Rap rapastinel, LMT locomotion test, TST tail suspension test, FST forced swimming test, SPT 1 % sucrose preference testCC BY · PubMed Central
Fig. 3 Levels of proBDNF and BDNF in the brain regions. a Western blot analysis of proBDNF in PFC, NAc, CA1, CA3, and DG of the hippocampus. The value was expressed as a percentage of that of control mice. The values represent the mean ± SEM (n = 6 or 7). N.S. not significant. b Western blot analysis of BDNF (mature form) in PFC, NAc, CA1, CA3, and DG of the hippocampus. The value was expressed as a percentage of that of control mice. The values represent the mean ± SEM (n = 6 or 7). *P < 0.05, **P < 0.01, ***P < 0.001 compared with the vehicle-treated stress group. # P < 0.05, ## P < 0.01 compared with R-ketamine treated stress group. N.S. not significant. Con control, Veh vehicle, R-Ket R-ketamine, Rap rapastinel
Fig. 3 Levels of proBDNF and BDNF in the brain regions. a Western blot analysis of proBDNF in PFC, NAc, CA1, CA3, and DG of the hippocampus. The value was expressed as a percentage of that of control mice. The values represent the mean ± SEM (n = 6 or 7). N.S. not significant. b Western blot analysis of BDNF (mature form) in PFC, NAc, CA1, CA3, and DG of the hippocampus. The value was expressed as a percentage of that of control mice. The values represent the mean ± SEM (n = 6 or 7). *P < 0.05, **P < 0.01, ***P < 0.001 compared with the vehicle-treated stress group. # P < 0.05, ## P < 0.01 compared with R-ketamine treated stress group. N.S. not significant. Con control, Veh vehicle, R-Ket R-ketamine, Rap rapastinelCC BY · PubMed Central
Fig. 4 The ratio of p-TrkB/TrkB in the brain regions. a Western blot analysis of TrkB and p-TrkB proteins in PFC, NAc, CA1, CA3, and DG of the hippocampus. The value of p-TrkB/TrkB ratio was expressed as a percentage of that of control mice. The values represent the mean± SEM (n = 6 or 7). *P < 0.05, **P < 0.01, ***P < 0.001 compared with the vehicle-treated stress group. # P < 0.05, ## P < 0.01 compared with R-ketamine treated stress group. N.S. not significant. b The value of total TrkB protein was expressed as a percentage of that of control mice. Values represent the mean ± SEM (n = 6 or 7). N.S. not significant, Con control, Veh vehicle, R-Ket R-ketamine, Rap rapastinel
Fig. 4 The ratio of p-TrkB/TrkB in the brain regions. a Western blot analysis of TrkB and p-TrkB proteins in PFC, NAc, CA1, CA3, and DG of the hippocampus. The value of p-TrkB/TrkB ratio was expressed as a percentage of that of control mice. The values represent the mean± SEM (n = 6 or 7). *P < 0.05, **P < 0.01, ***P < 0.001 compared with the vehicle-treated stress group. # P < 0.05, ## P < 0.01 compared with R-ketamine treated stress group. N.S. not significant. b The value of total TrkB protein was expressed as a percentage of that of control mice. Values represent the mean ± SEM (n = 6 or 7). N.S. not significant, Con control, Veh vehicle, R-Ket R-ketamine, Rap rapastinelCC BY · PubMed Central
Fig. 5 Levels of GluA1 and PSD-95 in the brain regions. a Western blot analysis of GluA1 in PFC, NAc, CA1, CA3, and DG of the hippocampus. The value was expressed as a percentage of that of control mice. Values represent the mean ± SEM (n = 6 or 7). *P < 0.05, **P < 0.01 compared with the vehicle-treated stress group. N.S. not significant. b Western blot analysis of PSD-95 in PFC, NAc, CA1, CA3, and DG of the hippocampus. The value was expressed as a percentage of that of control mice. Values represent the mean ± SEM (n = 6 or 7). *P < 0.05, **P < 0.01, ***P < 0.001 compared with the vehicle + stress group. # P < 0.05, ## P < 0.01 compared with R-ketamine treated stress group. N.S. not significant, Con control, Veh vehicle, R-Ket R-ketamine, Rap rapastinel
Fig. 5 Levels of GluA1 and PSD-95 in the brain regions. a Western blot analysis of GluA1 in PFC, NAc, CA1, CA3, and DG of the hippocampus. The value was expressed as a percentage of that of control mice. Values represent the mean ± SEM (n = 6 or 7). *P < 0.05, **P < 0.01 compared with the vehicle-treated stress group. N.S. not significant. b Western blot analysis of PSD-95 in PFC, NAc, CA1, CA3, and DG of the hippocampus. The value was expressed as a percentage of that of control mice. Values represent the mean ± SEM (n = 6 or 7). *P < 0.05, **P < 0.01, ***P < 0.001 compared with the vehicle + stress group. # P < 0.05, ## P < 0.01 compared with R-ketamine treated stress group. N.S. not significant, Con control, Veh vehicle, R-Ket R-ketamine, Rap rapastinelCC BY · PubMed Central
Fig. 6 Effects of i.v. administration of R-ketamine and rapastinel in social defeat stress model. a LMT (day 12), b TST (day 12), c FST (day 13), d SPT (day 14), e SPT (day 16), and f SPT (day 19). The values represent the mean ± SEM (n = 9). *P < 0.05, **P < 0.01, ***P < 0.001 compared with the vehicle-treated stress group. # P < 0.05 compared with R-ketamine treated stress group. N.S. not significant, Con control, Veh vehicle, R-Ket R-ketamine, Rap rapastinel, LMT locomotion test, TST tail suspension test, FST forced swimming test, SPT 1 % sucrose preference test
Fig. 6 Effects of i.v. administration of R-ketamine and rapastinel in social defeat stress model. a LMT (day 12), b TST (day 12), c FST (day 13), d SPT (day 14), e SPT (day 16), and f SPT (day 19). The values represent the mean ± SEM (n = 9). *P < 0.05, **P < 0.01, ***P < 0.001 compared with the vehicle-treated stress group. # P < 0.05 compared with R-ketamine treated stress group. N.S. not significant, Con control, Veh vehicle, R-Ket R-ketamine, Rap rapastinel, LMT locomotion test, TST tail suspension test, FST forced swimming test, SPT 1 % sucrose preference testCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 44 references

Cited by

See all 91

Metadata

Authors
Yang, B., Zhang, J.-C., Han, M., Yao, W., Yang, C., Ren, Q., Ma, M., Chen, Q.-X., & Hashimoto, K.
Affiliations
Chiba University (JP)
Corresponding author
Hashimoto, Kenji
Venue
Psychopharmacology
Published
2016-08-04
Volume
233
Issue
19-20
Pages
3647-3657
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2499491810
Cited by
91
References
44
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 5 · 2022: 9 · 2021: 11 · 2020: 7 · 2019: 14 · 2018: 14 · 2017: 19 · 2016: 3
FWCI
13.49
Type
journal article
Language
en
Open access
Locations
  • Psychopharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • KAKENHI, Japan (24116006)
  • The Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and development, AMED
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
(R)-ketamine, antidepressant effects, social defeat stress, NMDA receptor antagonists, BDNF/TrkB signaling, PSD-95, GluR1, AMPA receptors, synaptogenesis, prefrontal cortex, hippocampus, nucleus accumbens, rapid-acting antidepressants, depression
MeSH terms
Disks Large Homolog 4 Protein, Animals, Antidepressive Agents, Brain, Depression, Disease Models, Animal, Hippocampus, Ketamine, Male, Nucleus Accumbens, Oligopeptides, Stress, Psychological, Swimming, Prefrontal Cortex, Receptors, AMPA, Excitatory Amino Acid Antagonists, Dentate Gyrus, Brain-Derived Neurotrophic Factor, Hindlimb Suspension, Receptor, trkB, Mice, CA3 Region, Hippocampal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression. https://app.cochat.ai/papers/10.1007/s00213-016-4399-2
The paper
Yang, B., Zhang, J.-C., Han, M., Yao, W., Yang, C., Ren, Q., Ma, M., Chen, Q.-X., & Hashimoto, K. (2016). Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression. Psychopharmacology. https://doi.org/10.1007/s00213-016-4399-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.